Your browser doesn't support javascript.
loading
Phase I Study of Lysine-Specific Demethylase 1 Inhibitor, CC-90011, in Patients with Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin Lymphoma.
Hollebecque, Antoine; Salvagni, Stefania; Plummer, Ruth; Isambert, Nicolas; Niccoli, Patricia; Capdevila, Jaume; Curigliano, Giuseppe; Moreno, Victor; Martin-Romano, Patricia; Baudin, Eric; Arias, Marina; Mora, Sheila; de Alvaro, Juan; Di Martino, Jorge; Parra-Palau, Josep L; Sánchez-Pérez, Tania; Aronchik, Ida; Filvaroff, Ellen H; Lamba, Manisha; Nikolova, Zariana; de Bono, Johann S.
Affiliation
  • Hollebecque A; Institut Gustave Roussy, Villejuif, France. antoine.hollebecque@gustaveroussy.fr.
  • Salvagni S; Policlinico S. Orsola-Malpighi University Hospital, Bologna, Italy.
  • Plummer R; Clinical and Translational Research Institute Northern, Newcastle University, Newcastle, United Kingdom.
  • Isambert N; Centre Georges-François Leclerc, Dijon, France.
  • Niccoli P; Institut Paoli-Calmettes, Marseille, France.
  • Capdevila J; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Curigliano G; Istituto Europeo di Oncologia, IRCCS, Milan Italy.
  • Moreno V; University of Milano, Milan, Italy.
  • Martin-Romano P; START; Madrid-FJD, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
  • Baudin E; Institut Gustave Roussy, Villejuif, France.
  • Arias M; Institut Gustave Roussy, Villejuif, France.
  • Mora S; Centre for Innovation and Translational Research Europe, A Bristol Myers Squibb Company, Seville, Spain.
  • de Alvaro J; Centre for Innovation and Translational Research Europe, A Bristol Myers Squibb Company, Seville, Spain.
  • Di Martino J; Centre for Innovation and Translational Research Europe, A Bristol Myers Squibb Company, Seville, Spain.
  • Parra-Palau JL; Bristol Myers Squibb, Princeton, New Jersey.
  • Sánchez-Pérez T; Centre for Innovation and Translational Research Europe, A Bristol Myers Squibb Company, Seville, Spain.
  • Aronchik I; Centre for Innovation and Translational Research Europe, A Bristol Myers Squibb Company, Seville, Spain.
  • Filvaroff EH; Bristol Myers Squibb, Princeton, New Jersey.
  • Lamba M; Bristol Myers Squibb, Princeton, New Jersey.
  • Nikolova Z; Bristol Myers Squibb, Princeton, New Jersey.
  • de Bono JS; Centre for Innovation and Translational Research Europe, A Bristol Myers Squibb Company, Seville, Spain.
Clin Cancer Res ; 27(2): 438-446, 2021 01 15.
Article in En | MEDLINE | ID: mdl-33046517
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organic Chemicals / Lymphoma, Non-Hodgkin / Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: France Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organic Chemicals / Lymphoma, Non-Hodgkin / Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: France Country of publication: United States